Meeder Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-118
| Closed | -$19K | – | 2729 |
|
|
2021
Q2 | $19K | Buy |
118
+107
| +973% | +$17.9K | ﹤0.01% | 1480 |
|
|
2021
Q1 | $2K | Buy |
11
+5
| +83% | +$679 | ﹤0.01% | 2138 |
|
|
2020
Q4 | $1K | Sell |
6
-2,877
| -100% | -$322K | ﹤0.01% | 1795 |
|
|
2020
Q3 | $292K | Sell |
2,883
-1,088
| -27% | -$111K | 0.02% | 507 |
|
|
2020
Q2 | $387K | Sell |
3,971
-4,379
| -52% | -$408K | 0.03% | 434 |
|
|
2020
Q1 | $694K | Sell |
8,350
-7,574
| -48% | -$739K | 0.05% | 270 |
|
|
2019
Q4 | $1.77M | Buy |
15,924
+14,257
| +855% | +$1.47M | 0.11% | 171 |
|
|
2019
Q3 | $165K | Buy |
1,667
+993
| +147% | +$98.6K | 0.01% | 653 |
|
|
2019
Q2 | $67K | Buy |
674
+2
| +0.3% | +$191 | ﹤0.01% | 862 |
|
|
2019
Q1 | $74K | Sell |
672
-6,590
| -91% | -$689K | 0.01% | 777 |
|
|
2018
Q4 | $669K | Buy |
7,262
+5,276
| +266% | +$534K | 0.06% | 277 |
|
|
2018
Q3 | $219K | Buy |
1,986
+1,696
| +585% | +$177K | 0.02% | 494 |
|
|
2018
Q2 | $27.1K | Sell |
290
-269
| -48% | -$23.2K | ﹤0.01% | 896 |
|
|
2018
Q1 | $46K | Buy |
559
+232
| +71% | +$20.6K | ﹤0.01% | 696 |
|
|
2017
Q4 | $30K | Sell |
327
-1,409
| -81% | -$117K | ﹤0.01% | 821 |
|
|
2017
Q3 | $132K | Buy |
1,736
+201
| +13% | +$15.2K | 0.01% | 526 |
|
|
2017
Q2 | $115K | Buy |
1,535
+906
| +144% | +$62.8K | 0.01% | 539 |
|
|
2017
Q1 | $41K | Sell |
629
-1,650
| -72% | -$97.2K | ﹤0.01% | 639 |
|
|
2016
Q4 | $126K | Buy |
+2,279
| New | +$125K | 0.01% | 516 |
|
|
2016
Q3 | – | Sell |
-9,451
| Closed | -$395K | – | 1007 |
|
|
2016
Q2 | $395K | Buy |
9,451
+5,572
| +144% | +$257K | 0.04% | 467 |
|
|
2016
Q1 | $166K | Buy |
+3,879
| New | +$164K | 0.02% | 609 |
|
Other funds holding PRAH
Meeder Asset Management's PRAH Position: Q3 2021 in Review
Meeder Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 118 shares — an estimated $19K sold.
Meeder Asset Management first reported a position in PRAH in Q1 2016 and held it in 21 quarters. The position peaked at $1.77M in Q4 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Meeder Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Meeder Asset Management sold 118 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $19K.
- Meeder Asset Management first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 21 quarters.
- Meeder Asset Management's PRA Health Sciences, Inc. position peaked at $1.77M in Q4 2019.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Meeder Asset Management's 13F filing for Q3 2021, filed 8 Nov 2021.